Skip to content
AnalystLens

Archer-Daniels-Midland 8-K Report, Executive Changes (Jul 10, 2024)

Reports
Leadership Changes·Regulation FD·Exhibits & Filings
Filing Date
Filed July 10, 2024
Period End
July 3, 2024
Security
ADM
In the record · 2016–202610-K1210-Q368-K102

ADM filed 12 annual reports (10-K), 36 quarterly reports (10-Q) and 102 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Nov ’22Nov ’22
  2. Leadership change8-K · Aug ’26Aug ’26

01—Abstract

Summary

Summary of the 8-K filed July 10, 2024. Cited figures are marked; the original filing is the authoritative source.

On July 10, 2024, ADM announced the appointment of Monish Patolawala as Executive Vice President and Chief Financial Officer, effective August 1, 2024.

He succeeds Ismael Roig, who has served as Interim CFO since January 21, 2024, and who will continue as President of EMEA and President of Animal Nutrition. Patolawala most recently served as President and CFO of 3M, and previously held CFO roles at GE Healthcare and GE Transportation. He also sits on the Biogen Inc. board.

The filing is primarily a leadership transition disclosure rather than a financial-results update, so it contains no new earnings, guidance, or balance sheet information. The filing's most investor-relevant element is the compensation package, which signals the Board's intent to attract an experienced external CFO. Base salary is $1,425,000,a with a target annual bonus of $1,923,750 and an annual equity award of about $6.95 million (60% PSUs, 40% RSUs).

To offset awards forfeited from 3M, the company is providing a one-time $1.4 millionb cash make-whole payable in January 2025 and about $10 million in RSUs vesting over 18 months. The new CFO will oversee Global Finance and Accounting, Global Business Services, Global Technology, and Enterprise Strategy, so the appointment ends a period of interim finance leadership. For investors, the key takeaways are continuity and stability in finance leadership after roughly six months under an interim CFO, and an incoming executive whose background centers on operational discipline and transformation.

Because the release frames the appointment around productivity, operational excellence, and shareholder value, investors may look for follow-through on those priorities in upcoming earnings calls and filings. The filing does not describe any change in ADM's financial outlook.

02—Key points

Key Highlights

  1. Monish Patolawala named EVP and CFO effective August 1, 2024, succeeding interim CFO Ismael Roig (interim since January 21, 2024).
  2. Roig remains in the business as President of EMEA and President of Animal Nutrition, preserving internal continuity.
  3. Patolawala's background includes President and CFO of 3M, CFO of GE Healthcare, and CFO of GE Transportation, plus a current Biogen board seat.
  4. Base salary of $1,425,000 with a $1,923,750 target annual bonus and a ~$6.95M annual equity award (60% PSUs / 40% RSUs).
  5. One-time make-whole package to offset forfeited 3M awards: $1.4M cash (payable January 2025) and ~$10M RSUs vesting over 18 months.
  6. New CFO's remit covers Global Finance and Accounting, Global Business Services, Global Technology, and Enterprise Strategy.
  7. Filing contains no financial results, guidance, or outlook changes; it is a leadership and compensation disclosure.

03—Questions

Frequently Asked Questions

  1. Why did ADM hire a new CFO?

    ADM had been operating with an interim CFO, Ismael Roig, since January 21, 2024. The Board says the appointment follows a thorough search for a proven finance leader to oversee the finance team as the company pursues its strategic and operational priorities.

  2. What is Monish Patolawala's relevant experience?

    He most recently served as President and CFO of 3M, with earlier CFO roles at GE Healthcare (2015 to 2020) and GE Transportation (2010 to 2015). He also led operational transformation at General Electric from 2019 to 2020 and currently sits on the Biogen Inc. board.

  3. How is Patolawala being compensated?

    He receives a $1,425,000 base salary, a 2024 pro-rata target bonus of $1,923,750, and an annual equity award of about $6.95 million (60% PSUs, 40% RSUs). A one-time make-whole package of $1.4 million in cash (January 2025) and about $10 million in RSUs replaces awards he forfeits from 3M.

  4. What happens to Ismael Roig?

    Roig stops serving as Interim CFO and continues as President of EMEA and President of Animal Nutrition at ADM, so he remains with the company in senior operating roles.

  5. Does this announcement change ADM's financial outlook?

    No. The filing covers only the executive appointment, compensation, and a press release. It does not include new earnings results, guidance, or financial projections.

04—Continue

← View all 8-K filings